PPAR gamma ligands, rosiglitazone and pioglitazone, inhibit bFGF- and VEGF-mediated angiogenesis.
about
The role of dysregulated glucose metabolism in epithelial ovarian cancer.Anticancer Role of PPARgamma Agonists in Hematological Malignancies Found in the Vasculature, Marrow, and Eyes.Novel therapies targeting endometriosisAngiogenesis in rheumatoid arthritis.Methyl 2-cyano-3,11-dioxo-18-olean-1,12-dien-30-oate (CDODA-Me), a derivative of glycyrrhetinic acid, functions as a potent angiogenesis inhibitor.Antiangiogenic therapy for ischemic retinopathies.PPARγ activation but not PPARγ haplodeficiency affects proangiogenic potential of endothelial cells and bone marrow-derived progenitors.Molecular Implications of the PPARs in the Diabetic Eye.Peroxisome proliferator-activated receptors as stimulants of angiogenesis in cardiovascular disease and diabetes.Suppression of Rat Oral Carcinogenesis by Agonists of Peroxisome Proliferator Activated Receptor γ.Pioglitazone in the treatment of type 2 diabetes: safety and efficacy reviewAnti- and Protumorigenic Effects of PPARγ in Lung Cancer Progression: A Double-Edged SwordFatty acid binding protein 4 is a target of VEGF and a regulator of cell proliferation in endothelial cells.Activating peroxisome proliferator-activated receptor gamma mutant promotes tumor growth in vivo by enhancing angiogenesis.PPAR Gamma and Angiogenesis: Endothelial Cells Perspective.Pioglitazone inhibits HIF-1α-dependent angiogenesis in rats by paracrine and direct effects on endothelial cellsPPARs and angiogenesis.The Chick Embryo Chorioallantoic Membrane as an In Vivo Assay to Study Antiangiogenesis.Loss of miR125a expression in a model of K-ras-dependent pulmonary premalignancy.Innovative in vitro chemo-hormonal drug therapy for refractory thyroid carcinomas.Significance of LRP and PPAR-gamma Expression in Lipomatous Soft Tissue Tumors.PPARs: Interference with Warburg' Effect and Clinical Anticancer Trials.PPARγ activation inhibits cerebral arteriogenesis in the hypoperfused rat brain.Polymorphism of CYP46A1 and PPARγ2 Genes in Risk Prediction of Primary Open Angle Glaucoma Among North Indian Population.An ophthalmic solution of a peroxisome proliferator-activated receptor gamma agonist prevents corneal inflammation in a rat alkali burn modelIdentification of HIF-2α-regulated genes that play a role in human microvascular endothelial sprouting during prolonged hypoxia in vitro.The role of the tumor microenvironment in regulating angiogenesis.Interactions between TGF-β1, canonical WNT/β-catenin pathway and PPAR γ in radiation-induced fibrosis.Gestational Exposure to Sidestream (Secondhand) Cigarette Smoke Promotes Transgenerational Epigenetic Transmission of Exacerbated Allergic Asthma and Bronchopulmonary Dysplasia.Peroxisome proliferator-activated receptor-γ (PPAR-γ) activation confers functional neuroprotection in global ischemia.Combination therapy with telmisartan and parecoxib induces regression of endometriotic lesions.Targeting peroxisome proliferator-activated receptors: a novel strategy for Philadelphia chromosome-positive leukemia cells.Combined blockade of angiotensin II type 1 receptor and activation of peroxisome proliferator-activated receptor-γ by telmisartan effectively inhibits vascularization and growth of murine endometriosis-like lesions.Crosstalk Between Peroxisome Proliferator-Activated Receptor Gamma and the Canonical WNT/β-Catenin Pathway in Chronic Inflammation and Oxidative Stress During Carcinogenesis.
P2860
Q33674221-BDD592EC-577F-4BBA-8473-DDF8DC274B43Q33692555-F199C098-DD3D-40CD-9B9D-9DF4CDFC7D65Q33714186-B6F6024B-A6D0-408E-AB1F-B60D8D1DC589Q34051829-A55F02B9-9C6A-4E2C-A196-87FE2FBC78E9Q34214684-54C15F2F-DA37-40AD-98E6-667022C22326Q34295974-0C4BAE10-EA69-4566-A75B-4EC45A404B13Q34518904-B27924E4-641B-40E8-9003-8EB6791B187AQ34594935-AA6B6A0D-9D10-4B4D-A177-466236A151ACQ34620720-A3F948DE-3CCF-4015-B501-33ACEB0F6F47Q35827011-B9E1503D-8298-4F5C-89A3-5E3B4CEBCE49Q36139056-DCB4BEA3-28FA-4241-8DCC-A5EEA1405D12Q36183887-5DCAA5E8-8E4C-40BF-9DB8-0F54476B0B7CQ37415854-ED1F68E3-2D85-42A7-85A7-D26C27782D81Q37480201-0F5B37B3-A23F-49F3-ACBB-F6F0DC797FDDQ37521530-83480D70-EEFD-45B6-86E1-B5C853791434Q37707352-91B46344-38C6-45D2-BDFC-3270C8D2C09CQ37958934-B86F64EB-EBDD-46F7-A425-96FCFCEA4961Q38974193-31FA7DDE-5F0B-4073-8CAD-C08714323493Q38986353-650580F4-CF66-4824-8B16-E396A8589457Q39315979-C71018A9-44C4-485F-9C44-3B4B54EE7813Q39532764-9054945E-E161-4C73-8EC5-5445A913061EQ39609137-E6001521-9E0D-4B77-BF50-C5E11D5C0C97Q40143324-8CEAF904-15E2-4339-B209-12105C37476BQ40641339-CC9B00C7-D763-47FB-A601-DF65ABFBA2F1Q41828038-76F2BD53-924F-4119-97AF-7E5282A99442Q42086898-5CB95884-752D-4E7F-92C7-7864AF071294Q42703796-E63DB2F5-D186-4587-96DE-72434F774EFDQ47109594-EAF81612-1B02-4329-9278-9809F69A88E7Q47927411-966F3E68-3DFA-4D64-BC6A-7F01EBF2B920Q48176203-D26EEF5C-2937-4CBB-8457-492F638FD197Q48370696-B8E256A8-A73F-4146-A574-DDF6EA0393CCQ50642755-DB3B08B1-A0AF-4F70-9F95-FCF67C5DC0EEQ51157373-150EEEBC-9A70-46AE-AA14-5F89B7E2A76CQ52715797-E540DCA5-ED43-46AE-8344-72966FB198F5
P2860
PPAR gamma ligands, rosiglitazone and pioglitazone, inhibit bFGF- and VEGF-mediated angiogenesis.
description
2008 nî lūn-bûn
@nan
2008年の論文
@ja
2008年学术文章
@wuu
2008年学术文章
@zh
2008年学术文章
@zh-cn
2008年学术文章
@zh-hans
2008年学术文章
@zh-my
2008年学术文章
@zh-sg
2008年學術文章
@yue
2008年學術文章
@zh-hant
name
PPAR gamma ligands, rosiglitaz ...... nd VEGF-mediated angiogenesis.
@en
PPAR gamma ligands, rosiglitaz ...... nd VEGF-mediated angiogenesis.
@nl
type
label
PPAR gamma ligands, rosiglitaz ...... nd VEGF-mediated angiogenesis.
@en
PPAR gamma ligands, rosiglitaz ...... nd VEGF-mediated angiogenesis.
@nl
prefLabel
PPAR gamma ligands, rosiglitaz ...... nd VEGF-mediated angiogenesis.
@en
PPAR gamma ligands, rosiglitaz ...... nd VEGF-mediated angiogenesis.
@nl
P2093
P2860
P1433
P1476
PPAR gamma ligands, rosiglitaz ...... and VEGF-mediated angiogenesis
@en
P2093
Ahmad Aljada
Laura O'Connor
P2860
P2888
P304
P356
10.1007/S10456-008-9118-0
P577
2008-09-23T00:00:00Z